Attached files
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): April 12, 2012
BIOCUREX, INC.
----------------------------------
(Name of Small Business Issuer in its charter)
Texas 0-26947 75-2742601
---------------------------- ------------------ ------------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
7080 River Road, Suite 215
Richmond, British Columbia , Canada V6X 1X5
----------------------------------------------------
(Address of Principal Executive Offices, including Zip Code)
Registrant's telephone number, including area code: (866) 884-8669
N/A
------------------------------------------
(Former name or former address if changed since last report)
Item 9.01. Financial Statements and Exhibits
Exhibit No. Description
----------- -----------
23 Consent of the Company's independent registered public accounting
firm to the incorporation by reference of their auditor's report
dated March 29, 2012 in the Company's Registration Statement on
Form S-8 (File No. 333-174613).
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: April 12, 2012
BIOCUREX, INC.
By:/s/ Dr. Ricardo Moro
-------------------------------------
Dr. Ricardo Moro, President
